The medtech sector is holding its ground in 2026, driven by a convergence of AI integration, point-of-care diagnostics, and interventional oncology gaining real clinical momentum….
April 14, 2026
March 16, 2026
Boston Scientific Secures Strategic Manufacturing License to Lead China’s Medtech Market
Boston Scientific Corporation (NYSE: BSX) is currently expanding its global footprint by securing a landmark manufacturing license in the Chinese market. This strategic achievement allows…